18th February 2022 | Pharma Updates
Sun Pharma receives nod to market Tofacitinib
The drug is indicated for the treatment of patients with active psoriatic arthritis and rheumatoid arthritis.
Lacto Calamine Expands its Offerings
The brand has roped in Bollywood actor Amyra Dastur as the brand ambassador
FDA Clears Roflumilast
Roflumilast tablets are a generic version of AstraZeneca’s oral Daliresp. Zydus Pharma will market these tablets at a dose of 500 mcg.
FDA Okays IND Application for Human Studies of Therapeutic for Retinal Disorders
Kato Pharma will evaluate the safety and efficacy of Resolv ER for the treatment of vitreomacular attachment.
EvoEndo Wins US FDA Clearance for Single-Use Unsedated Transnasal Endoscopy System
With EvoEndo System there is no need for general anaesthesia or conscious sedation while performing routine upper endoscopic procedures
Wearable Neurostimulation Device Gets Breakthrough Designation from American Drug Regulator
A wearable neurostimulation device is designed for reducing moderate to severe chemotherapy-induced peripheral neuropathy that persists for around six months after chemotherapy sessions.
First FDA-cleared Video Game to Treat Kids with ADHD
The video game is developed to increase attentional control by strengthening brain activity involved in focus and multitasking.
Agios obtains FDA nod for Mitapivat
The drug activates an enzyme called pyruvate kinase-R that RBCS use to convert sugars into energy.
TytoCare Gets Conformitè Europëenne Mark for Lung Sounds Analyzer
The device has the capacity to detect abnormal breath sounds in recordings, such as wheezing in adults and kids.
Boston Scientific buys Baylis Medical
Boston Scientific has completed the acquisition of Baylis Medical Company, which is known for offering advanced transseptal access solutions as well as guidewires, sheaths and dilators used to aid catheter-based left-heart procedures.